Skip to content
Boca Raton City Online – Lifestyle
Author:
Castle Biosciences, Inc.
Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma’s i31-SLNB, Identifying T1b–T2a Melanoma Patients Who May Safely Avoid SLNB
March 9, 2026
Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas
March 9, 2026
Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis
March 7, 2026
Castle Biosciences to Release Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call on Thursday, Feb. 26, 2026
March 5, 2026
←
Previous Page
1
2